TrialCancer chemotherapy and pharmacology2025
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
Masaki Ri et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it